The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Smetanina M.A.

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia

Shadrina A.S.

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia;
Novosibirsk State University, Novosibirsk, Russia

Zolotukhin I.A.

Pirogov Russian National Research Medical University, Moscow, Russia

Seliverstov E.I.

Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia

Filipenko M.L.

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia;
Novosibirsk State University, Novosibirsk, Russia

Differentially Expressed Genes in Varicose Veins Disease: Current State of the Problem, Analysis of the Published Data

Authors:

Smetanina M.A., Shadrina A.S., Zolotukhin I.A., Seliverstov E.I., Filipenko M.L.

More about the authors

Journal: Journal of Venous Disorders. 2017;11(4): 190‑204

DOI: 10.17116/flebo2017114190-202

Read: 4251 times

Download PDF (RU)
Contact the author
Table of contents

DIFFERENTIALLY EXPRESSED GENES IN VARICOSE VEINS DISEASE: CURRENT STATE OF THE PROBLEM, ANALYSIS OF THE PUBLISHED DATA
DIFFERENTIALLY EXPRESSED GENES IN VARICOSE VEINS DISEASE: CURRENT STATE OF THE PROBLEM, ANALYSIS OF THE PUBLISHED DATA

To cite this article:

Smetanina MA, Shadrina AS, Zolotukhin IA, Seliverstov EI, Filipenko ML. Differentially Expressed Genes in Varicose Veins Disease: Current State of the Problem, Analysis of the Published Data. Journal of Venous Disorders. 2017;11(4):190‑204. (In Russ.)
https://doi.org/10.17116/flebo2017114190-202

Подписка 2026 Флебология (Journal of Venous Disorders)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The Effect of Standardized Doses of Hesperidin and Diosmin on Venous Wall Remo­deling in Patients with Primary Vari­cose Veins: a Prospective Controlled Study “STANDARD”. Journal of Venous Diso­rders. 2024;(4):293-301
Significance of Local Microcirculation Para­meters in Predicting the Resu­lts of Surgical Treatment of Vari­cose Veins with Trophic Diso­rders. Journal of Venous Diso­rders. 2025;(1):6-14
Clinical and Ultrasound Semiotics of Vari­cose Vein Recu­rrence. Journal of Venous Diso­rders. 2025;(1):28-36
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59
Infe­ctious factors in atopic dermatitis, pharmaceutical possibilities (systematic lite­rature review). Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):7-15
A modern perspective on the pathogenesis of proliferative diabetic reti­nopathy. Russian Annals of Ophthalmology. 2025;(1):92-98
Analysis of differential gene expression in myocardial tissue from patients with hype­rtrophic cardiomyopathy. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(1):17-23
Abstract:

Varicose veins of the lower extremities (VVs) are a common pathology of blood vessels. Molecular mechanisms underlying its development are still not fully understood. One of the approaches to the study of pathogenesis of the diseases is to compare gene expression in normal and pathological conditions, e.g. in normal and varicose veins. In this article, we collected and analyzed the literature data on the differential gene expression in VVs, discussed the methods and approaches used for its investigation, and highlighted problems in this field of research. Three types of studies were analyzed: candidate-gene studies (23 studies), differential displays of mRNA (3), and microarray-based studies (3). We also performed a functional annotation of the genes identified with the microarray technology by means of the Gene Set Enrichment Analysis. This analysis was conducted using the tools of the PANTHER system and the geneXplain platform. The enrichment was calculated for the gene ontologies «biological process», «molecular function», and for Reactome pathways. Many categories that showed statistically significant overrepresentation were related to the organization of cellular and extracellular structures — the cytoskeleton, the extracellular matrix, the interaction of matrix components with cells and between each other, as well as to the response to various organic molecules, including cytokines, and to the hemostatic system.

Keywords:

varicose veins
gene expression
pathogenesis

Authors:

Smetanina M.A.

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia

Shadrina A.S.

Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia;
Novosibirsk State University, Novosibirsk, Russia

Zolotukhin I.A.

Pirogov Russian National Research Medical University, Moscow, Russia

Seliverstov E.I.

Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia

Filipenko M.L.

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia;
Novosibirsk State University, Novosibirsk, Russia

Close metadata

References:

  1. Carpentier P, Maricq H, Biro C, Ponçot-Makinen C, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg. 2004;40(4):650-659. https://doi.org/10.1016/j.jvs.2004.07.025
  2. Segiet O, Brzozowa M, Piecuch A, Dudek D, Reichman-Warmusz E, Wojnicz R. Biomolecular mechanisms in varicose veins development. Ann Vasc Surg. 2015;29(2):377-384. https://doi.org/10.1016/j.avsg.2014.10.009
  3. Zolotukhin I, Seliverstov E, Shevtsov Y, Avakiants I, Nikishkov A, Tatarintsev A, Kirienko A. Prevalence and risk factors for chronic venous disease in Russian General Population. Eur J Vasc Endovasc Surg. 2017. https://doi.org/10.1016/j.ejvs.2017.08.033
  4. Pocock E, Alsaigh T, Mazor R, Schmid-Schönbein G. Cellular and molecular basis of venous insufficiency. Vasc Cell. 2014;6(1):24. https://doi.org/10.1186/s13221-014-0024-5
  5. Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins ‒ lessons from biomechanics. Vasa. 2014;43(2):88-99. https://doi.org/10.1024/0301-1526/a000335
  6. Guzik B, Chwała M, Matusik P, Ludew D, Skiba D, Wilk G, Mrowiecki W, Batko B, Cencora A, Kapelak B, Sadowski J, Korbut R, Guzik T. Mechanisms of increased vascular superoxide production in human varicose veins. Pol Arch Med Wewnętrznej. 2011;121(9):279-286.
  7. Lim C, Gohel M, Shepherd A, Paleolog E, Davies A. Venous hypoxia: a poorly studied etiological factor of varicose veins. J Vasc Res. 2011;48(3):185-194. https://doi.org/10.1159/000320624
  8. Lim C, Davies A. Pathogenesis of primary varicose veins. Br J Surg. 2009;96(11):1231-1142. https://doi.org/10.1002/bjs.6798
  9. Oklu R, Habito R, Mayr M, Deipolyi A, Albadawi H, Hesketh R, Walker T, Linskey K, Long C, Wicky S, Stoughton J, Watkins M. Pathogenesis of varicose veins. J Vasc Interv Radiol. 2012;23(1):33-39;quiz 40. https://doi.org/10.1016/j.jvir.2011.09.010
  10. Poredos P, Spirkoska A, Rucigaj T, Fareed J, Jezovnik M. Do blood constituents in varicose veins differ from the systemic blood constituents? Eur J Vasc Endovasc Surg. 2015;50(2):250-256. https://doi.org/10.1016/j.ejvs.2015.04.031
  11. Gomez I, Benyahia C, Le Dall J, Payré C, Louedec L, Leséche G, Lambeau G, Longrois D, Norel X. Absence of inflammatory conditions in human varicose saphenous veins. Inflamm Res. 2013;62(3):299-308. https://doi.org/10.1007/s00011-012-0578-8
  12. del Rio Solá L, Aceves M, Dueñas A, González-Fajardo J, Vaquero C, Crespo M, García-Rodríguez C. Varicose veins show enhanced chemokine expression. Eur J Vasc Endovasc Surg. 2009;38(5):635–641. https://doi.org/10.1016/j.ejvs.2009.07.021
  13. Urbanek T, Skop B, Wiaderkiewicz R, Wilczok T, Ziaja K, Lebda-Wyborny T, Pawlicki K. Smooth muscle cell apoptosis in primary varicose veins. Eur J Vasc Endovasc Surg. 2004;28(6):600-611. https://doi.org/10.1016/j.ejvs.2004.09.008
  14. Kowalewski R, Malkowski A, Sobolewski K, Gacko M. Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins. J Surg Res. 2009;155(1):165-172. https://doi.org/10.1016/j.jss.2008.07.032
  15. Sansilvestri-Morel P, Rupin A, Jullien N, Lembrez N, Mestries-Dubois P, Fabiani J, Verbeuren T. Decreased production of collagen type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res. 2005;42(5):388-398. https://doi.org/10.1159/000087314
  16. Xu Y, Bei Y, Li Y, Chu H. Phenotypic and functional transformation in smooth muscle cells derived from varicose veins. J Vasc Surgery Venous Lymphat Disord. 2017;5(5):723-733. https://doi.org/10.1016/j.jvsv.2017.04.009
  17. Görmüs U, Timirci-Kahraman O, Ergen A, Kunt A, Isbir S, Dalan A, Isbir T. Expression levels of elastin and related genes in human varicose veins. Folia Biol. 2014;60(2):68-73.
  18. Gillespie D, Patel A, Fileta B, Chang A, Barnes S, Flagg A, Kidwell M, Villavicencio J, Rich N. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res. 2002;106(2):233-238. https://doi.org/10.1006/jsre.2002.6455
  19. Görmüş U, Kahraman O, Isbir S, Tekeli A, Isbir T. MMP2 gene polymorphisms and MMP2 mRNA levels in patients with superficial varices of lower extremities. In Vivo. 2011;25(3):387-391.
  20. Hollingsworth S, Powell G, Barker S, Cooper D. Primary varicose veins: altered transcription of VEGF and its receptors (KDR, flt-1, soluble flt-1) with sapheno-femoral junction incompetence. Eur J Vasc Endovasc Surg. 2004;27(3):259-268. https://doi.org/10.1016/j.ejvs.2003.12.015
  21. Flórez A, De Haro J, Bleda S, Varela C, Esparza L, Acin F. Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency. Phlebology. 2013;28(1):32-37. https://doi.org/10.1258/phleb.2011.011102
  22. Tang X, Guo D, Lin C, Shi Z, Qian R, Fu W, Liu J, Li X, Fan L. Upregulation of the gene expression of CLOCK is correlated with hypoxia-inducible factor 1α in advanced varicose lesions. Mol Med Rep. 2015;12(4):6164-6170. https://doi.org/10.3892/mmr.2015.4223
  23. Lim C, Kiriakidis S, Paleolog E, Davies A. Increased activation of the hypoxia-inducible factor pathway in varicose veins. J Vasc Surg. 2012;55(5):1427-1439.e1. https://doi.org/10.1016/j.jvs.2011.10.111
  24. Jacob T, Hingorani A, Ascher E. Overexpression of transforming growth factor–β1 correlates with increased synthesis of nitric oxide synthase in varicose veins. J Vasc Surg. 2005;41(3):523-530. https://doi.org/10.1016/j.jvs.2004.12.044
  25. Kowalewski R, Malkowski A, Sobolewski K, Gacko M. Evaluation of transforming growth factor-β signaling pathway in the wall of normal and varicose veins. Pathobiology. 2010;77(1):1-6. https://doi.org/10.1159/000272948
  26. Surendran S, Girijamma A, Nair R, Ramegowda K, Nair D, Thulaseedharan J, Lakkappa R, Kamalapurkar G, Kartha C. Forkhead box C2 promoter variant c.-512C>T is associated with increased susceptibility to chronic venous diseases. PLoS One. 2014;9(3):e90682. https://doi.org/10.1371/journal.pone.0090682
  27. Surendran S, Ramegowda K, Suresh A, Binil Raj S, Lakkappa R, Kamalapurkar G, Radhakrishnan N, Kartha C. Arterialization and anomalous vein wall remodeling in varicose veins is associated with upregulated FoxC2-Dll4 pathway. Lab Investig. 2016;96(4):399-408. https://doi.org/10.1038/labinvest.2015.167
  28. Takase S, Bergan J, Schmid-Schönbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg. 2000;14(5):427-435. https://doi.org/10.1007/s100169910092
  29. Bertrand-Thiebault C, Ferrari L, Boutherin-Falson O, Kockx M, Desquand-Billiald , Fichelle J, Nottin R, Renaud J, Batt A, Visvikis S. Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: linkage with varicosis. Clin Exp Pharmacol Physiol. 2004;31(5-6):295-301. https://doi.org/10.1111/j.1440-1681.2004.03996.x
  30. Huang X, Jin Y, Zhou D, Xu G, Huang J, Shen L. IQGAP1 promotes the phenotypic switch of vascular smooth muscle by myocardin pathway: a potential target for varicose vein. Int J Clin Exp Pathol. 2014;7(10):6475-6485.
  31. Wang X, Zhao R, Liu C, Qiao T. Abnormal expression of Tie1 on the valves of great saphenous varicose vein. Phlebology. 2013;28(2):93-100. https://doi.org/10.1258/phleb.2012.012018
  32. Chen S, Qin S, Wang M, Zhang S. Expression and significance of NELIN and SM22α in varicose vein tissue. Exp Ther Med. 2015;9(3):845-849. https://doi.org/10.3892/etm.2015.2170
  33. Serra R, Gallelli L, Perri P, De Francesco E, Rigiracciolo D, Mastroroberto P, Maggiolini M, de Franciscis S. Estrogen receptors and chronic venous disease. Eur J Vasc Endovasc Surg. 2016;52(1):114-118. https://doi.org/10.1016/j.ejvs.2016.04.020
  34. Frolov AE, Godwin TK, Favorova OO. Differential gene expression analysis by DNA microarrays technology and its application in molecular oncology. Molecular Biology. 2003:37(4):573-584. (In Russ.) https://doi.org/10.1023/A%3A1025166706481
  35. Kim D, Eo H, Joh J. Identification of differentially expressed genes in primary varicose veins. J Surg Res. 2005;123(2):222-226. https://doi.org/10.1016/j.jss.2004.08.003
  36. Yin H, Zhang X, Wang J, Yin W, Zhang G, Wang S, Liu Q. Downregulation of desmuslin in primary vein incompetence. J Vasc Surg. 2006;43(2):372-378. https://doi.org/10.1016/j.jvs.2005.10.018
  37. Jeong G, Choi E, Chang J. Octamer-binding transcription factor-1 gene is upregulated in primary varicose veins. Ann Vasc Surg. 2008;22(1):115-120. https://doi.org/10.1016/j.avsg.2007.08.003
  38. Lee S, Lee W, Choe Y, Kim D, Na G, Im S, Kim J, Kim M, Kim J, Cho J. Gene expression profiles in varicose veins using complementary DNA microarray. Dermatol Surg. 2005;31(4):391-395.
  39. Cario-Toumaniantz C, Boularan C, Schurgers L, Heymann M, Le Cunff M, Léger J, Loirand G, Pacaud P. Identification of differentially expressed genes in human varicose veins: involvement of matrix Gla protein in extracellular matrix remodeling. J Vasc Res. 2007;44(6):444-459. https://doi.org/10.1159/000106189
  40. Markovic J, Shortell C. Genomics of varicose veins and chronic venous insufficiency. Semin Vasc Surg. 2013;26(1):2-13. https://doi.org/10.1053/j.semvascsurg.2013.04.003
  41. Barallobre-Barreiro J, Oklu R, Lynch M, Fava M, Baig F, Yin X, Barwari T, Potier D, Albadawi H, Jahangiri M, Porter K, Watkins M, Misra S, Stoughton J, Mayr M. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins. Cardiovasc Res. 2016;110(3):419-430. https://doi.org/10.1093/cvr/cvw075
  42. Haider S, Pal R. Integrated analysis of transcriptomic and proteomic data. Curr Genomics. 2013;14(2):91-110. https://doi.org/10.2174/1389202911314020003
  43. Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J, Davis A, Dolinski K, Dwight S, Eppig J, Harris M, Hill D, Issel-Tarver L, Kasarskis A, Lewis S, Matese J, Richardson J, Ringwald M, Rubin G, Sherlock G. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25-29. https://doi.org/10.1038/75556
  44. Mi H, Muruganujan A, Casagrande J, Thomas P. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc. 2013;8(8):1551-1566. https://doi.org/10.1038/nprot.2013.092
  45. Rahman F, Wotton C, Goldacre M. Varicose veins, haemorrhoids and the risk of circulatory diseases: record-linkage study. Clin Epidemiol. 2011;18:124-129.
  46. York A, Hutchinson E, Fodor E. Interactome analysis of the influenza A virus transcription/replication machinery identifies protein phosphatase 6 as a cellular factor required for efficient virus replication. J Virol. 2014;88(22):13284-13299. https://doi.org/10.1128/JVI.01813-14
  47. Gilman M. Ribonuclease protection assay. Current Protocols in Molecular Biology. 2001;Chapter 4:Unit 4.7. https://doi.org/10.1002/0471142727.mb0407s24
  48. Ghaderian S, Lindsey N, Graham A, Homer-Vanniasinkam S, Najar R. Pathogenic mechanisms in varicose vein disease: the role of hypoxia and inflammation. Pathology. 2010;42(5):446-453. https://doi.org/10.3109/00313025.2010.493865
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.